Dirui Industrial Co Ltd - Asset Resilience Ratio
Dirui Industrial Co Ltd (300396) has an Asset Resilience Ratio of 3.90% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Dirui Industrial Co Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2013–2025)
This chart shows how Dirui Industrial Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Dirui Industrial Co Ltd (300396) total assets.
Liquid Assets Composition Over Time
This chart breaks down Dirui Industrial Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 300396 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥100.08 Million | 3.9% |
| Total Liquid Assets | CN¥100.08 Million | 3.90% |
Asset Resilience Insights
- Limited Liquidity: Dirui Industrial Co Ltd maintains only 3.90% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Dirui Industrial Co Ltd Industry Peers by Asset Resilience Ratio
Compare Dirui Industrial Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Stratec SE
XETRA:SBS |
Medical Devices | 0.29% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
DRTECH Corporation
KQ:214680 |
Medical Devices | 5.18% |
|
Novacyt
PA:ALNOV |
Medical Devices | 0.02% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.48% |
Annual Asset Resilience Ratio for Dirui Industrial Co Ltd (2013–2025)
The table below shows the annual Asset Resilience Ratio data for Dirui Industrial Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 6.50% | CN¥180.32 Million ≈ $26.39 Million |
CN¥2.77 Billion ≈ $405.64 Million |
+6.50pp |
| 2023-12-31 | 0.01% | CN¥185.85K ≈ $27.20K |
CN¥3.32 Billion ≈ $485.93 Million |
-5.83pp |
| 2022-12-31 | 5.83% | CN¥170.61 Million ≈ $24.96 Million |
CN¥2.93 Billion ≈ $428.06 Million |
-11.91pp |
| 2021-12-31 | 17.74% | CN¥421.40 Million ≈ $61.66 Million |
CN¥2.38 Billion ≈ $347.63 Million |
+13.60pp |
| 2019-12-31 | 4.14% | CN¥85.43 Million ≈ $12.50 Million |
CN¥2.06 Billion ≈ $301.78 Million |
+4.13pp |
| 2018-12-31 | 0.01% | CN¥171.21K ≈ $25.05K |
CN¥1.99 Billion ≈ $291.04 Million |
0.00pp |
| 2017-12-31 | 0.01% | CN¥212.70K ≈ $31.12K |
CN¥1.85 Billion ≈ $270.86 Million |
0.00pp |
| 2016-12-31 | 0.01% | CN¥248.03K ≈ $36.30K |
CN¥1.86 Billion ≈ $271.94 Million |
0.00pp |
| 2015-12-31 | 0.02% | CN¥274.84K ≈ $40.22K |
CN¥1.77 Billion ≈ $258.56 Million |
-5.72pp |
| 2014-12-31 | 5.73% | CN¥60.00 Million ≈ $8.78 Million |
CN¥1.05 Billion ≈ $153.17 Million |
+1.15pp |
| 2013-12-31 | 4.58% | CN¥25.00 Million ≈ $3.66 Million |
CN¥546.01 Million ≈ $79.90 Million |
-- |
About Dirui Industrial Co Ltd
Dirui Industrial Co.,Ltd. researches, develops, produces, and sells ng instruments and related reagents and test strips products in the People's Republic of China. It offers urine analysis, biochemical analysis, chemiluminescence immunoassay, gynecological secretion analysis, blood cell analysis, coagulation analysis, and integrated laboratory solutions. The company was founded in 1992 and is hea… Read more